An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB

Clin Toxicol (Phila). 2019 Jan;57(1):69-71. doi: 10.1080/15563650.2018.1497170. Epub 2018 Nov 15.

Ann M Arens^{1

2}, Travis D Olives^{1

2}, Nicholas S Simpson², JoaAn R Laes^{1

3}, Deborah L Anderson¹, Stacey A Bangh¹, Samantha C Lee¹, Spencer Martin⁴, Samuel D Banister⁵, Roy R Gerona⁶, Jon B Cole¹

¹ a Minnesota Poison Control System , Minneapolis , MN , USA.
² b Department of Emergency Medicine , Hennepin Healthcare , Minneapolis , MN , USA.
³ c Division of Addiction Medicine , Hennepin Healthcare , Minneapolis , MN , USA.
⁴ d University of California, San Francisco School of Medicine , San Francisco , CA , USA.
⁵ e The Lambert Initiative for Cannabinoid Therapeutics, University of Sydney , Camperdown , Australia.
⁶ f Clinical Toxicology and Environmental Biomonitoring Laboratory , University of California , San Francisco , CA , USA.

No abstract available

Publication types